Bristol Myers’ (BMY) Breyanzi Label Expansion Application Validated
ZacksBristol Myers’ (BMY) application to expand Breyanzi’s label for the treatment of adult patients with relapsed or refractory follicular lymphoma gets EMA validation.
Bristol Myers’ (BMY) application to expand Breyanzi’s label for the treatment of adult patients with relapsed or refractory follicular lymphoma gets EMA validation.